NO mechanisms in N2O antinociception in inbred mice
NO mechanisms in N2O antinociception in inbred mice
批准号:
7191775
负责人:
RAYMOND MARK QUOCK
金额:
$21.26万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-01 至 2010-12-31
关键词:
Absence of pain sensationAnalgesicsAnesthesia and AnalgesiaBiologicalBiological AssayBrainC57BL/6 MouseClinical ManagementCoenzymesDBA/2 MouseDataDevelopmentDoseEffectivenessElementsEnd PointEnvironmentEnzymesExposure toGoalsInbred MouseInbred StrainInbred Strains MiceKnock-outKnockout MiceKnowledgeLaboratoriesLocalizedMeasurementMeasuresMediatingMethodsMolecularMolecular BiologyMouse StrainsMusNOS1 protein, humanNeuronsNeurosciencesNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INitrous OxideNociceptionOpioidOpioid PeptideOpioid ReceptorPainPain managementPatientsPharmaceutical PreparationsPharmacogeneticsPharmacologyPlayPost-Translational Protein ProcessingProceduresProteinsRangeResearchResearch PersonnelResourcesRodentRoleSpinalSpinal CordStudentsStudy SectionSystemTechniquesTestingTherapeutic Interventionbasedrug developmentendogenous opioidsenzyme activityexpectationexperienceinstrumentationneurochemistrypromoterresponsesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lack of understanding of the role of neuronal nitric oxide synthase (nNOS) and nitric oxide ( problem because, without it, researchers may be overlooking alternative targets that might be exploited in pain management. Our long-term goal is to increase the efficacy of clinical management of pain. The objective in this application is to identify the role of induced antinociception in mice. Our central hypothesis is that the poor responsiveness of the DBA/2 strain to N2O might be due to an anomaly in the enzyme, cofactor, promoter strength/response or post-translational modification) that is involved in N2O-induced antinociception. By taking advantage of the differential responsiveness of two inbred strains (C5BL/6 and DBA/2) to N2O, this research will garner increased knowledge of the role of to N2O. The Specific Aims of the proposed research include the following: 1) determination of the role of spinal and supraspinal N2O-induced antinociception in NOS knockout and knockdown mice; 2) establishing the dose-response relationship between drugs that increase brain induced antinociception in C57BL/6 and DBA/2 mice; and 3) measurement and comparison of the effects of N2O exposure on mice. These goals will be attained by pharmacological, neurochemical and molecular biology methods. This contribution will be significant because it is expected that new targets for therapeutic intervention will be identified and development of new drugs that can optimize pain management will be stimulated. Our long-term goal is to increase the effectiveness of clinical management of pain. The rationale for the proposed research is to identify and localize new targets for development of drugs (and possibly non-drug) means that can be used to optimize pain management.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.lfs.2013.12.207
发表时间:
2014-03-07
期刊:
LIFE SCIENCES
影响因子:
6.1
作者:
[Liu, Shulin, Shirachi, Donald Y., Quock, Raymond M.]
通讯作者:
Quock, Raymond M.
DOI:
10.1016/j.brainres.2013.08.050
发表时间:
2013-11-06
期刊:
Brain research
影响因子:
2.9
作者:
[Gibbons CR, Liu S, Zhang Y, Sayre CL, Levitch BR, Moehlmann SB, Shirachi DY, Quock RM]
通讯作者:
Quock RM
DOI:
10.1016/j.jpain.2008.08.003
发表时间:
2009-02
期刊:
The journal of pain
影响因子:
--
作者:
[Zelinski LM, Ohgami Y, Chung E, Shirachi DY, Quock RM]
通讯作者:
Quock RM
DOI:
10.1016/j.brainres.2010.10.079
发表时间:
2011-01-12
期刊:
Brain research
影响因子:
2.9
作者:
[Quock LP, Zhang Y, Chung E, Ohgami Y, Shirachi DY, Quock RM]
通讯作者:
Quock RM
DOI:
10.1016/j.brainres.2009.08.091
发表时间:
2009-12-01
期刊:
BRAIN RESEARCH
影响因子:
2.9
作者:
[Zelinski, Lisa M., Ohgami, Yusuke, Quock, Raymond M.]
通讯作者:
Quock, Raymond M.
共 9 条
Hyperbaric Oxygen: A Novel Approach to Treatment of Chronic Pain
-
批准号:8430875
-
项目类别:
-
资助金额:$22.89万
-
财政年份:2012
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
Hyperbaric Oxygen: A Novel Approach to Treatment of Chronic Pain
-
批准号:8543641
-
项目类别:
-
资助金额:$17.19万
-
财政年份:2012
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
SIGNALING PATHWAY FOR BENZODIAZEPINE INDUCED BEHAVIORS
-
批准号:2013564
-
项目类别:
-
资助金额:$9.25万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:6017457
-
项目类别:
-
资助金额:$10.84万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:2013429
-
项目类别:
-
资助金额:$13.71万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:2749123
-
项目类别:
-
资助金额:$2.09万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
SIGNALING PATHWAY FOR BENZODIAZEPINE INDUCED BEHAVIORS
-
批准号:2634036
-
项目类别:
-
资助金额:$9.08万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
GENETIC CONTROL OF RESPONSIVENESS TO N20 ANTIOCICEPTION
-
批准号:2897994
-
项目类别:
-
资助金额:$7.71万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
SIGNALING PATHWAY FOR BENZODIAZEPINE INDUCED BEHAVIORS
-
批准号:2856550
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1997
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE CONSCIOUS SEDATION--ANXIOYSIS
-
批准号:3425483
-
项目类别:
-
资助金额:$2.22万
-
财政年份:1990
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDORPHINS
-
批准号:3220395
-
项目类别:
-
资助金额:$6.05万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:3220392
-
项目类别:
-
资助金额:$23.26万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDORPHINS
-
批准号:3220396
-
项目类别:
-
资助金额:$6.48万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:2129410
-
项目类别:
-
资助金额:$19.28万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:3220397
-
项目类别:
-
资助金额:$20.78万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDOGENOUS OPIOID SYSTEMS
-
批准号:3220394
-
项目类别:
-
资助金额:$0.21万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
NITROUS OXIDE AND ENDORPHINS
-
批准号:3220387
-
项目类别:
-
资助金额:$6.07万
-
财政年份:1984
-
负责人:RAYMOND MARK QUOCK
-
依托单位:
海外基金